Clinical Research Management, a Full-Service CRO, Changes Its Name to ClinicalRM
Clinical Research Management announced it is changing its name to ClinicalRM to support the company’s strategic business growth and to better differentiate itself among providers of clinical trial and research services for both pharmaceuticals and medical devices.
In conjunction with the name change, ClinicalRM is also launching a new website designed to increase communication to sponsors and partners regarding their range of capabilities and sponsor services.
When asked about a name change, Victoria Tifft, CEO and Founder of ClinicalRM responded, “When we started our business nearly two decades ago, Web URLs and e-mail addresses had very little to do with an identity. Since then, the world has come to rely on your web identity as your corporate identify. In this day and age, we need to make it easy for our prospective clients to find us and hear the ClinicalRM story.”
When asked “Why now?” Ms. Tifft described the growth strategies put in place to proactively add new customers to its long list of satisfied clients. “After years of organic growth, our board decided to take a more proactive position on growth. Understanding who you are, where you’ve been, and where you are headed is crucial to executing a growth strategy."
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
